CD4+ T cells promote the pathogenesis of Staphylococcus aureus pneumonia
Dane Parker1, Chanelle L Ryan1, Francis Alonzo2
1Department of Pediatrics, Columbia University.
Abstract:
We postulated that the activation of proinflammatory signaling by methicillin-resistant Staphylococcus aureus (MRSA) strain USA300 is a major factor in the pathogenesis of severe pneumonia and a target for immunomodulation. Local activation of T cells in the lung was a conserved feature of multiple strains of S. aureus, in addition to USA300. The pattern of Vβ chain activation was consistent with known superantigens, but deletion of SelX or SEK and SEQ was not sufficient to prevent T-cell activation, indicating the participation of multiple genes. Using Rag2(-/-), Cd4(-/-), and Cd28(-/-) mice, we observed significantly improved clearance of MRSA from the airways and decreased lung pathology, compared with findings for wild-type controls. The improved outcome correlated with decreased production of proinflammatory cytokines (tumor necrosis factor, KC, interleukin 6, and interleukin 1β). Our data suggest that T-cell-mediated hypercytokinemia induced by infection with MRSA strain USA300 contributes to pathogenesis and may be a therapeutic target for improving outcomes of this common infection in a clinical setting.
Insights
Methicillin-resistant Staphylococcus aureus (MRSA) triggers severe pneumonia by activating T cells and causing excessive inflammation. Targeting this T-cell response may offer a new treatment for MRSA pneumonia.
Area of Science:
- Immunology
- Microbiology
- Infectious Diseases
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) USA300 strain is a significant cause of severe pneumonia.
- Proinflammatory signaling and T-cell activation are implicated in MRSA pneumonia pathogenesis.
Purpose of the Study:
- To investigate the role of T-cell activation in MRSA pneumonia.
- To explore T-cell-mediated hypercytokinemia as a therapeutic target.
Main Methods:
- Studied T-cell activation in the lungs of mice infected with MRSA.
- Utilized genetically modified mice (Rag2(-/-), Cd4(-/-), Cd28(-/-)) to assess the impact of T-cell deficiency.
- Measured cytokine production and bacterial clearance.
Main Results:
- MRSA infection consistently activated T cells in the lungs across different strains.
- Mice lacking T-cell signaling components showed improved MRSA clearance and reduced lung pathology.
- Reduced proinflammatory cytokine levels correlated with better outcomes in immunodeficient mice.
Conclusions:
- T-cell-mediated hypercytokinemia contributes to MRSA pneumonia pathogenesis.
- Targeting T-cell activation presents a potential therapeutic strategy for severe MRSA infections.
Related Concept Videos
Pneumonia II: Pathophysiology
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Bacterial Meningitis II: Pathophysiology
Atypical Pneumonia
Staphylococcal Skin Infections
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...


